Ceftazidime Inj.

Ceftazidime Inj.

Description

Indications

Ceftid for injection USP is a semisynthetic third generation cephalosporin intended for intravenous and intramuscular administration. It is highly resistant to most beta-lactamases and is active against a wide range of gram+ve and gram-ve bacteria including Pseudomonas aeruginosa.

Lower resipiratory tract infections
Urinay tract infections
Septicemia
Gastro intestinal infections
Severe infection in ICU patients
Skin & soft tissue infections

Product variants & features

Product	Strength	Features	Presentation
CEFTID / BIOZID / BACTAZID	250 mg 500 mg 1 mg	Excellent coverage against P. aeruginosa The peak plasma concentration following 1gm I.V. administration: 69 mcg / ml. Penetrates in bile, peritoneal fluid, CSF Serum protein binding : 10% No evidence of accumulation with repeated infusions About 81% - 90% excreted in the urine as unchanged drug Dose: Twice a day	Glass vial + 5 ml SWFI Glass vial + 10 ml SWFI